BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19054816)

  • 21. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population.
    Dieudé P; Guedj M; Wipff J; Ruiz B; Riemekasten G; Matucci-Cerinic M; Melchers I; Hachulla E; Airo P; Diot E; Hunzelmann N; Cabane J; Mouthon L; Cracowski JL; Riccieri V; Distler J; Meyer O; Kahan A; Boileau C; Allanore Y
    Ann Rheum Dis; 2010 Nov; 69(11):1958-64. PubMed ID: 20511617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis.
    Romano E; Rosa I; Fioretto BS; Kosalka-Wegiel J; Sticchi E; Bellando-Randone S; Manetti M; Matucci-Cerinic M
    Clin Exp Rheumatol; 2022 Oct; 40(10):1921-1925. PubMed ID: 34665708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-10 gene promoter and NFKB1 promoter insertion/deletion polymorphisms in systemic sclerosis.
    Salim PH; Jobim M; Bredemeier M; Chies JA; Brenol JC; Jobim LF; Xavier RM
    Scand J Immunol; 2013 Feb; 77(2):162-8. PubMed ID: 23237063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis.
    Carmona FD; Gutala R; Simeón CP; Carreira P; Ortego-Centeno N; Vicente-Rabaneda E; García-Hernández FJ; García de la Peña P; Fernández-Castro M; Martínez-Estupiñán L; Egurbide MV; Tsao BP; Gourh P; Agarwal SK; Assassi S; Mayes MD; Arnett FC; Tan FK; Martín J;
    Ann Rheum Dis; 2012 Jan; 71(1):114-9. PubMed ID: 21926187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patients.
    Radstake TR; Vonk MC; Dekkers M; Schijvenaars MM; Treppichio WL; Lafyatis R; Riemekasten G; van den Hoogen F; Coenen MJ
    Hum Immunol; 2009 Feb; 70(2):130-3. PubMed ID: 19032966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor.
    Bossini-Castillo L; Simeon CP; Beretta L; Broen J; Vonk MC; Callejas JL; Carreira P; Rodríguez-Rodríguez L; García-Portales R; González-Gay MA; Castellví I; Camps MT; Tolosa C; Vicente-Rabaneda E; Egurbide MV; ; Schuerwegh AJ; Hesselstrand R; Lunardi C; van Laar JM; Shiels P; Herrick A; Worthington J; Denton C; Radstake TR; Fonseca C; Martin J
    Arthritis Res Ther; 2012 Dec; 14(6):R273. PubMed ID: 23270786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
    Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis.
    Bossini-Castillo L; Campillo-Davó D; López-Isac E; Carmona FD; Simeon CP; Carreira P; Callejas-Rubio JL; Castellví I; Fernández-Nebro A; Rodríguez-Rodríguez L; Rubio-Rivas M; García-Hernández FJ; Madroñero AB; Beretta L; Santaniello A; Lunardi C; Airó P; Hoffmann-Vold AM; Kreuter A; Riemekasten G; Witte T; Hunzelmann N; Vonk MC; Voskuyl AE; de Vries-Bouwstra J; Shiels P; Herrick A; Worthington J; Radstake TRDJ; Martin J;
    J Rheumatol; 2017 Oct; 44(10):1453-1457. PubMed ID: 28668810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis.
    Teruel M; Simeon CP; Broen J; Vonk MC; Carreira P; Camps MT; García-Portales R; Delgado-Frías E; Gallego M; Espinosa G; ; Beretta L; Airó P; Lunardi C; Riemekasten G; Witte T; Krieg T; Kreuter A; Distler JH; Hunzelmann N; Koeleman BP; Voskuyl AE; Schuerwegh AJ; González-Gay MA; Radstake TR; Martin J
    Arthritis Res Ther; 2012 Jun; 14(3):R154. PubMed ID: 22731751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CTGF polymorphism associated with systemic sclerosis.
    Gourh P; Mayes MD; Arnett FC
    N Engl J Med; 2008 Jan; 358(3):308-9; author reply 309. PubMed ID: 18203332
    [No Abstract]   [Full Text] [Related]  

  • 31. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity.
    Koumakis E; Giraud M; Dieudé P; Cohignac V; Cuomo G; Airò P; Hachulla E; Matucci-Cerinic M; Diot E; Caramaschi P; Mouthon L; Riccieri V; Cracowski JL; Tiev KP; Francès C; Amoura Z; Sibilia J; Cosnes A; Carpentier P; Valentini G; Manetti M; Guiducci S; Meyer O; Kahan A; Boileau C; Chiocchia G; Allanore Y
    Arthritis Rheum; 2012 Aug; 64(8):2746-52. PubMed ID: 22488580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
    Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
    Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis.
    Arismendi M; Giraud M; Ruzehaji N; Dieudé P; Koumakis E; Ruiz B; Airo P; Cusi D; Matucci-Cerinic M; Salvi E; Cuomo G; Hachulla E; Diot E; Caramaschi P; Riccieri V; Avouac J; Kayser C; Allanore Y
    Arthritis Res Ther; 2015 Mar; 17(1):71. PubMed ID: 25880423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort.
    Bossini-Castillo L; Broen JC; Simeon CP; Beretta L; Vonk MC; Ortego-Centeno N; Espinosa G; Carreira P; Camps MT; Navarrete N; González-Escribano MF; Vicente-Rabaneda E; Rodríguez L; Tolosa C; Román-Ivorra JA; Gómez-Gracia I; García-Hernández FJ; Castellví I; Gallego M; Fernández-Nebro A; García-Portales R; Egurbide MV; Fonollosa V; de la Peña PG; Pros A; González-Gay MA; Hesselstrand R; Riemekasten G; Witte T; Coenen MJ; Koeleman BP; Houssiau F; Smith V; de Keyser F; Westhovens R; De Langhe E; Voskuyl AE; Schuerwegh AJ; Chee MM; Madhok R; Shiels P; Fonseca C; Denton C; Claes K; Padykov L; Nordin A; Palm O; Lie BA; Airó P; Scorza R; van Laar JM; Hunzelmann N; Kreuter A; Herrick A; Worthington J; Radstake TR; Martín J; Rueda B
    Ann Rheum Dis; 2011 Apr; 70(4):638-41. PubMed ID: 21187296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme gene does not contribute to genetic susceptibility to systemic sclerosis in European Caucasians.
    Wipff J; Gallier G; Dieude P; Avouac J; Tiev K; Hachulla E; Granel B; Diot E; Sibilia J; Mouthon L; Meyer O; Kahan A; Varret M; Boileau C; Allanore Y
    J Rheumatol; 2009 Feb; 36(2):337-40. PubMed ID: 19132786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FOXP3, ICOS and ICOSL gene polymorphisms in systemic sclerosis: FOXP3 rs2294020 is associated with disease progression in a female Italian population.
    D'Amico F; Fiorito G; Skarmoutsou E; Granata M; Rossi GA; Trovato C; Bellocchi C; Marchini M; Beretta L; Mazzarino MC
    Immunobiology; 2018 Jan; 223(1):112-117. PubMed ID: 29030005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insight on the Xq28 association with systemic sclerosis.
    Carmona FD; Cénit MC; Diaz-Gallo LM; Broen JC; Simeón CP; Carreira PE; Callejas-Rubio JL; Fonollosa V; López-Longo FJ; González-Gay MA; Hunzelmann N; Riemekasten G; Witte T; Kreuter A; Distler JH; Madhok R; Shiels P; van Laar JM; Schuerwegh AJ; Vonk MC; Voskuyl AE; Fonseca C; Denton CP; Herrick A; Worthington J; Arnett FC; Tan FK; Assassi S; Radstake TR; Mayes MD; Martín J;
    Ann Rheum Dis; 2013 Dec; 72(12):2032-8. PubMed ID: 23444193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single nucleotide polymorphisms of the HIF1A gene are associated with susceptibility to pulmonary arterial hypertension in systemic sclerosis and contribute to SSc-PAH disease severity.
    Takagi K; Kawamoto M; Higuchi T; Tochimoto A; Harigai M; Kawaguchi Y
    Int J Rheum Dis; 2020 May; 23(5):674-680. PubMed ID: 32144871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype.
    Dieudé P; Bouaziz M; Guedj M; Riemekasten G; Airò P; Müller M; Cusi D; Matucci-Cerinic M; Melchers I; Koenig W; Salvi E; Wichmann HE; Cuomo G; Hachulla E; Diot E; Hunzelmann N; Caramaschi P; Mouthon L; Riccieri V; Distler J; Tarner I; Avouac J; Meyer O; Kahan A; Chiocchia G; Boileau C; Allanore Y
    Arthritis Rheum; 2011 Dec; 63(12):3979-87. PubMed ID: 21898345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility.
    González-Serna D; Carmona EG; Ortego-Centeno N; Simeón CP; Solans R; Hernández-Rodríguez J; Tolosa C; Castañeda S; Narváez J; Martinez-Valle F; ; ; Witte T; Neumann T; Holle J; Beretta L; Boiardi L; Emmi G; Cimmino MA; Vaglio A; Herrick AL; Denton CP; Salvarani C; Cid MC; Morgan AW; Fonseca C; González-Gay MA; Martín J; Márquez A
    PLoS One; 2018; 13(12):e0209343. PubMed ID: 30586461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.